$HIMS a BUY???

Here's why:

• 📈 Stock Jump: Hims & Hers (HIMS) shares went up 5.4% in pre-market trading.

• 🩺 FDA News: The FDA might allow drug compounders to sell versions of Eli Lilly’s weight-loss and diabetes drugs.

• 💊 Growth Opportunity: If allowed, Hims could offer affordable alternatives to these popular meds, potentially boosting sales.

• 📊 High Demand: Weight-loss and diabetes treatments are big markets, with growing demand in the U.S.

• ⚖️ Regulatory Risks: FDA rules can change, so there’s some uncertainty, but this news is positive for Hims’ growth potential.

Disclaimer: I bought to close out my puts to book a 50% gain in less than a trading day